Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.

Daniel SullivanChul AhnAng GaoChantale LacelleFernando TorresSrinivas BollineniAmit BangaJessica MullinsManish MohankaSteve RingMichael WaitMatthias PeltzPavan DuddupudiDhiraj SurapaneniVaidehi Kaza

Published in: Clinical transplantation (2018)

Donor-specific antibodies prevalence is high after lung transplantation. Clearance of DSA correlated with improved outcomes. Current therapeutic strategies against DSA are relatively ineffective. Multicenter collaborative studies will be required to evaluate current treatment strategies and other innovative modalities.

Keyphrases

public health
risk factors
quality improvement
adipose tissue
metabolic syndrome
skeletal muscle